1,558
Views
0
CrossRef citations to date
0
Altmetric
Clinical Study

Tuberculous peritonitis in patients on peritoneal dialysis: a 35-year experience from a large medical center in Northern Taiwan

, , , , &
Article: 2153064 | Received 10 Oct 2022, Accepted 23 Nov 2022, Published online: 12 Jan 2023

References

  • USRDS. USRDS annual data report: epidemiology of kidney disease in the United States. National institutes of health, national institute of diabetes and digestive and kidney diseases Bethesda (MD). 2021.
  • USRDS. USRDS annual data report: chapter 11 international comparisons. National institutes of health, national institute of diabetes and digestive and kidney diseases. Bethesda (MD). 2018.
  • Chou KJ, Fang HC, Bai KJ, et al. Tuberculosis in maintenance dialysis patients. Nephron. 2001;88(2):138–143.
  • Ram R, Swarnalatha G, Akpolat T, et al. Mycobacterium tuberculous peritonitis in CAPD patients: a report of 11 patients and review of literature. Int Urol Nephrol. 2013;45(4):1129–1135.
  • Lui SL, Tang S, Li FK, et al. Tuberculosis infection in chinese patients undergoing continuous ambulatory peritoneal dialysis. Am J Kidney Dis. 2001;38(5):1055–1060.
  • Hung YM, Chan HH, Chung HM. Tuberculous peritonitis in different dialysis patients in Southern Taiwan. Am J Trop Med Hyg. 2004;70(5):532–535.
  • Moore DA, Lightstone L, Javid B, et al. High rates of tuberculosis in end-stage renal failure: the impact of international migration. Emerg Infect Dis. 2002;8(1):77–78.
  • Hussein MM, Mooij JM, Roujouleh H. Tuberculosis and chronic renal disease. Semin Dial. 2003;16(1):38–44.
  • Romanowski K, Clark EG, Levin A, et al. Tuberculosis and chronic kidney disease: an emerging global syndemic. Kidney Int. 2016; 90(1):34–40.
  • National Health Research Institutes & Taiwan Society of Nephrology. Annual report on kidney disease in Taiwan. 2020.
  • Talwani R, Horvath JA. Tuberculous peritonitis in patients undergoing continuous ambulatory peritoneal dialysis: case report and review. Clin Infect Dis. 2000;31(1):70–75.
  • Akpolat T. Tuberculous peritonitis. Perit Dial Int. 2009;29(Suppl 2):S166–S169.
  • Tamayo-Isla RA, de la Cruz MC, Okpechi IG. Mycobacterial peritonitis in CAPD patients in Limpopo: a 6-Year cumulative report from a single center in South Africa. Perit Dial Int. 2016;36(2):218–222.
  • WHO. Global tuberculosis report 2021. 2021.
  • Hsueh PR, Liu YC, So J, et al. Mycobacterium tuberculosis in Taiwan. J Infect. 2006;52(2):77–85.
  • Bai KJ, Huang KC, Lee CH, et al. Effect of pulmonary tuberculosis on clinical outcomes of long-term dialysis patients: pre- and post-DOTS implementation in Taiwan. Respirology. 2017;22(5):991–999.
  • MacNeil A, Glaziou P, Sismanidis C, et al. Global epidemiology of tuberculosis and progress toward achieving global targets - 2017. MMWR Morb Mortal Wkly Rep. 2019;68(11):263–266.
  • Taiwan Centers for Diseases Control. Taiwan Tuberculosis Control Report 2020. 2021.
  • Sanai FM, Bzeizi KI. Systematic review: tuberculous peritonitis–presenting features, diagnostic strategies and treatment. Aliment Pharmacol Ther. 2005;22(8):685–700.
  • Li PK, Szeto CC, Piraino B, et al. ISPD peritonitis recommendations: 2016 update on prevention and treatment. Perit Dial Int. 2016; 36(5):481–508.
  • Lui SL, Choy LC, Chan BY, et al. Optimal treatment and long-term outcome of tuberculous peritonitis complicating continuous ambulatory peritoneal dialysis. Am J Kidney Dis. 1996;28(5):747–751.
  • Waness A, Al Shohaib S. Tuberculous peritonitis associated with peritoneal dialysis. Saudi J Kidney Dis Transpl. 2012;23(1):44–47.
  • Lin JH, Wang WJ, Yang HY, et al. Non-tuberculous and tuberculous mycobacterial peritonitis in peritoneal dialysis patients. Ren Fail. 2014;36(7):1158–1161.
  • Thomson BKA, Vaughan S, Momciu B. Mycobacterium tuberculosis peritonitis in peritoneal dialysis patients: a scoping review. Nephrology (Carlton). 2022;27(2):133–144.
  • Rohit A, Abraham G. Peritoneal dialysis related peritonitis due to Mycobacterium spp.: a case report and review of literature. J Epidemiol Glob Health. 2016;6(4):243–248.
  • Uzunkoy A, Harma M, Harma M. Diagnosis of abdominal tuberculosis: experience from 11 cases and review of the literature. World J Gastroenterol. 2004;10(24):3647–3649.
  • Li PK, Chow KM, Cho Y, et al. ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment. Perit Dial Int. 2022;42(2):110–153.
  • Global tuberculosis report 2022. Licence: CC BY-NC-SA 3.0 IGO. World Health Organization, Geneva. 2022.
  • Taiwan Centers for Disease Control. Tuberculosis incidence rate in Taiwan, https://www.cdc.gov.tw/En/Category/ListContent/bg0g_VU_Ysrgkes_KRUDgQ?uaid=0WialNbsh7SEGERJLa29FA
  • Ayelign B, Negash M, Genetu M, et al. Immunological impacts of diabetes on the susceptibility of Mycobacterium tuberculosis. J Immunol Res. 2019;2019:6196532.
  • Martinez N, Kornfeld H. Diabetes and immunity to tuberculosis. Eur J Immunol. 2014;44(3):617–626.
  • Gupta N, Prakash KC. Asymptomatic tuberculous peritonitis in a CAPD patient. Perit Dial Int. 2001;21(4):416–417.
  • Chen KH, Chang CT, Weng SM, et al. Culture-negative peritonitis: a fifteen-year review. Ren Fail. 2007; 29(2):177–181.